dronabinol has been researched along with Pruritus in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 5 (71.43) | 29.6817 |
2010's | 1 (14.29) | 24.3611 |
2020's | 1 (14.29) | 2.80 |
Authors | Studies |
---|---|
Lou, K; Murphy, S; Talbot, C | 1 |
Boger, DL; Cravatt, BF; Lichtman, AH; Schlosburg, JE | 1 |
Conrad, DH; Lichtman, AH; O'Neal, ST; Schlosburg, JE | 1 |
Amaro, R; Bergasa, NV; Chase, V; Jeffers, L; Molina, E; Neff, GW; O'Brien, CB; Reddy, KR; Regev, A; Rodriguez, MJ; Schiff, E | 1 |
Blumenstein, I; Schirrmacher, S; Stein, J | 1 |
Dvorak, M; McGlone, F; Rukwied, R; Watkinson, A | 1 |
Ernst, G; Kongsgaard, UE | 1 |
1 review(s) available for dronabinol and Pruritus
Article | Year |
---|---|
[Use of cannabinoids in palliative medicine].
Topics: Analgesics, Non-Narcotic; Antiemetics; Appetite; Cannabinoids; Dronabinol; Humans; Nausea; Neuralgia; Pain; Palliative Care; Pruritus; Receptors, Cannabinoid | 2008 |
1 trial(s) available for dronabinol and Pruritus
Article | Year |
---|---|
Histamine induced responses are attenuated by a cannabinoid receptor agonist in human skin.
Topics: Administration, Topical; Adult; Axons; Cannabinoid Receptor Agonists; Capillary Permeability; Dronabinol; Ethanol; Female; Histamine; Histamine Antagonists; Humans; Iontophoresis; Male; Microdialysis; Proteins; Pruritus; Regional Blood Flow; Skin; Vasodilation | 2003 |
5 other study(ies) available for dronabinol and Pruritus
Article | Year |
---|---|
Cannabinoids for the treatment of refractory neuropathic pruritus in amyotrophic lateral sclerosis: A case report.
Topics: Amyotrophic Lateral Sclerosis; Cannabinoids; Dronabinol; Humans; Middle Aged; Pain; Pruritus | 2022 |
Endocannabinoid modulation of scratching response in an acute allergenic model: a new prospective neural therapeutic target for pruritus.
Topics: Amidohydrolases; Animals; Antipruritics; Behavior, Animal; Benzamides; Cannabinoid Receptor Modulators; Carbamates; Cell Degranulation; Dermatitis, Contact; Dose-Response Relationship, Drug; Dronabinol; Endocannabinoids; Enzyme Inhibitors; Genotype; Mast Cells; Mice; Mice, Inbred C57BL; Mice, Inbred ICR; p-Methoxy-N-methylphenethylamine; Pruritus; Pyridines; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Receptors, Cannabinoid | 2009 |
CB1 receptors mediate rimonabant-induced pruritic responses in mice: investigation of locus of action.
Topics: Animals; Behavior, Animal; Disease Models, Animal; Dose-Response Relationship, Drug; Dronabinol; Female; Histamine H1 Antagonists; Hypersensitivity; Injections, Intraperitoneal; Injections, Intraventricular; Injections, Spinal; Injections, Subcutaneous; Loratadine; Male; Mast Cells; Mice; Mice, Inbred C57BL; Mice, Knockout; Pain; Piperidines; Pruritus; Pyrazoles; Receptor, Cannabinoid, CB1; Rimonabant | 2011 |
Preliminary observation with dronabinol in patients with intractable pruritus secondary to cholestatic liver disease.
Topics: Adult; Analgesics, Non-Narcotic; Cholestasis, Intrahepatic; Chronic Disease; Dronabinol; Female; Humans; Middle Aged; Pruritus | 2002 |
[Pathogenesis and treatment of pruritus in patients with cholestasis].
Topics: Brain; Cholestasis; Cholestyramine Resin; Dronabinol; Enzyme Induction; Humans; Liver; Narcotic Antagonists; Ondansetron; Opioid Peptides; Phenobarbital; Pruritus; Rifampin; Skin; Synaptic Transmission; Treatment Outcome | 2003 |